ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Patient Engagement Web Platform from ICON Bolsters Clinical Connectivity
An Outsourcing Pharma article featuring commentary from EB McLindon & Gretchen Goller, on ICON’s new web-based patient engagement platform.
US Healthcare Reform Scenarios
There has been growing interest among politicians & the public for significant change of the US healthcare system.
ICON Introduces New Platform for Potential Trial Participants
A Clinical Trials Arena article on ICON's new patient engagement platform, supporting people interested in participating in clinical trials.
A New Horizon
A PharmaTimes article featuring commentary from Tom O’Leary on the future of AI in healthcare.
Adopting mHealth Technologies in CV Trials
A Pharmafile article authored by Marie McCarthy and Jack Martin on the use of mHealth technologies in cardiovascular trials.
Rare Disease Trials Q&A
A PME article discussing the challenges of rare disease trials, including those of recruitment and retention unique to rare disease studies.
The Need for New Business Models under MDR/IVDR
A thought leadership article on the approaching deadline for the new medical devices regulation (MDR) & in vitro diagnostic device regulation (IVDR).
ICER's Growing Impact On Drug Pricing And Reimbursement
Read Forbes' article featuring ICON research insights exploring how ICER may have a greater impact on payer decision-making than expected.
The Rise of Patient-Centricity
In the April 2019 issue of PME, ICON's Matt McCarty discusses the importance of understanding what patients value and ways to gather patient insights.
ICON CIO – Telemedicine, Wearables & AI Could Boost Clinical Trial Participation
A Diginomica article featuring commentary from Tom O’Leary, discussing the opportunities for technology to overcome key challenges in clinical trials.